MDM2 and neoplasm: Previous studies have shown that in monocytes, MDM2 can bind to p53 to inhibit the anti-tumor activity, while MDM2 can bind to p53 to inhibit the killing (Namgaladze and Brüne 2021) effect of NK cells on tumor cells (Veneziani et al. 2021).